Altersberger, Valerian L.
Enz, Lukas S.
Sibolt, Gerli
Hametner, Christian
Nannoni, Stefania
Heldner, Mirjam R.
Stolp, Jeffrey
Jovanovic, Dejana R.
Zini, Andrea
Pezzini, Alessandro
Wegener, Susanne
Cereda, Carlo W.
Ntaios, George
Räty, Silja
Gumbinger, Christoph
Heyse, Miriam
Polymeris, Alexandros A.
Zietz, Annaelle
Schaufelbuehl, Anna
Strambo, Davide
Padlina, Giovanna
Slavova, Nedelina
Tiainen, Marjaana
Valkonen, Kati
Velzen, Twan J. van
Bigliardi, Guido
Stanarcevic, Predrag
Magoni, Mauro
Luft, Andreas
Bejot, Yannick
Vandelli, Laura
Padjen, Visnja
Nederkoorn, Paul J.
Arnold, Marcel
Michel, Patrik
Ringleb, Peter A.
Curtze, Sami
Engelter, Stefan T.
Gensicke, Henrik
,
Funding for this research was provided by:
University of Basel
Article History
Received: 9 January 2022
Revised: 1 May 2022
Accepted: 3 May 2022
First Online: 27 May 2022
Declarations
:
: V.L. Altersberger, G. Sibolt, A. Zietz, A. Schaufelbühl, A. Polymeris, C. Hametner, M. Heyse, G. Bigliardi, J. Stolp, T.J. van Velzen, G. Padlina, N. Slavova, M. Tiainen, K. Valkonen, L. Vandelli, M. Magoni, A. Luft, A. Pezzini, S. Nannoni, S. Räty, and S. Curtze report no disclosures. Lukas S Enz has received funding from the Swiss National Science Foundation (323530_171139). M.R. Heldner reports Scientific Advisory honoraria by Amgen and a grant from the Bangerter foundation, outside the submitted work. A. Zini has received funding for speaker honoraria and consulting fees from Boehringer-Ingelheim and Medtronic, speaker honoraria from Cerenovus, for scientific advisory board from Boehringer-Ingelheim and Stryker. V. Padjen travel or speaker honoraria from Boehringer Ingelheim and Pfizer; honoraria from scientific advisory board from Medtronic. C. Gumbinger is the head of the commission telestroke service of the German Stroke Society (DSG). D. Strambo has received congress travel support from Bristol-Myers Squibb, and research grant from the Swiss Heart Foundation and from the University of Lausanne. All fees are paid to his institution. C.W. Cereda has received modest honoraria for scientific advisory board from Bayer, Boehringer-Ingelheim and iSchemaview; Research grants from the Swiss Heart Foundation. Susanne Wegener received research funds by the Swiss National Science Foundation, the UZH Clinical research priority program (CRPP) stroke, the Swiss Heart foundation, Boehringer- Ingelheim, a speaker honorarium from Amgen and a consultancy fee from Bayer. Y. Béjot reports personal fees from AstraZeneca, BMS, Pfizer, Medtronic, MSD France, Amgen, Servier, and Boehringer-Ingelheim, outside the submitted work. D.R. Jovanović has received for travel or speaker honoraria from Bayer, Boehringer Ingelheim, Pfizer, Sanofi and Medtronic. She has served on scientific advisory board for Boehringer Ingelheim. P. Stanarcevic has received travel or speaker honoraria from Boehringer Ingelheim, Pfizer and Sandoz; also, honoraria from scientific advisory board from Medtronic and Boehringer Ingelheim. P. Michel has received has received through his institution research grants from the Swiss National Science Foundation, the Swiss Heart Foundation and the ERISTA program (Pfizer/BMS); and consulting fees from Medtronic. All this support is goes to his institution and is used for stroke education and research. P.A. Ringleb has received modest honoraria for lectures and advisory board from Boehringer-Ingelheim. The University Hospital Heidelberg is sponsor of the ECASS4-trial, examining the role of rtPA in an extended time-window, which is financed by Boehringer-Ingelheim. M. Arnold received Speaker honoraria from Bayer, Boehringer Ingelheim, and Covidien; Scientific advisory board honoraria from Amgen, Bayer, Boehringer Ingelheim, BMS, Pfizer, Covidien, Daichy Sankyo and Nestlé Health Science. Research grants from the Swiss Heart Foundation and the Swiss National Science Foundation. P.J. Nederkoorn has received funding from the Dutch heart foundation for acute stroke intervention trials in the Collaboration for New Trials in Stroke (CONTRAST) consortium. S.T. Engelter has received funding for travel or speaker honoraria from Bayer Boehringer-Ingelheim, and Daiichi-Sankyo. He has served on scientific advisory boards for Bayer, Boehringer-Ingelheim, BMS/Pfizer, MindMaze and on the editorial board of Stroke. He has received an educational grant from Pfizer and research support from the Science Funds (Wissenschaftsfonds) of the University Hospital Basel, the University Basel, the Swiss Heart Foundation and the Swiss National Science Foundation. H. Gensicke has received research support from the Swiss National Science Foundation, advisory board honoraria from Daiichi Sankyo and funding for travel from BMS/Pfizer.
: The study was approved by the ethics committee in Basel, Switzerland and written informed consent was waived. The requirement for additional local ethical approval differed between participating centers and was obtained if required.